Trial Profile
Special Drug Use Investigation of Zevalin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2011
Price :
$35
*
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Ibritumomab tiuxetan
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms ZEVALIN-SDUI
- Sponsors Bayer
- 28 Nov 2011 New trial record